msh (11-13) has been researched along with chitosan in 2 studies
Studies (msh (11-13)) | Trials (msh (11-13)) | Recent Studies (post-2010) (msh (11-13)) | Studies (chitosan) | Trials (chitosan) | Recent Studies (post-2010) (chitosan) |
---|---|---|---|---|---|
23 | 0 | 2 | 27,648 | 232 | 21,257 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dalmasso, G; Laroui, H; Merlin, D; Nguyen, HT; Sitaraman, SV; Yan, Y | 1 |
Han, MK; Kang, Y; Merlin, D; Viennois, E; Xiao, B; Xu, Z; Zhang, M; Zhang, Y; Zhang, Z | 1 |
2 other study(ies) available for msh (11-13) and chitosan
Article | Year |
---|---|
Drug-loaded nanoparticles targeted to the colon with polysaccharide hydrogel reduce colitis in a mouse model.
Topics: Administration, Oral; Alginates; Animals; Anti-Inflammatory Agents; Caco-2 Cells; Chemistry, Pharmaceutical; Chitosan; Colitis; Colon; Dextran Sulfate; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Carriers; Drug Compounding; Female; Gastrointestinal Agents; Glucuronic Acid; Hexuronic Acids; Humans; Hydrogels; Intestinal Mucosa; Melanocyte-Stimulating Hormones; Mice; Mice, Inbred C57BL; Nanoparticles; Peptide Fragments; Polysaccharides; Solubility; Time Factors | 2010 |
Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis.
Topics: Administration, Oral; Alginates; Animals; Anti-Inflammatory Agents; Chitosan; Colitis, Ulcerative; Drug Carriers; Drug Compounding; Epithelial Cells; Gene Expression; Glucuronic Acid; Hexuronic Acids; Humans; Hyaluronic Acid; Hydrogels; Macrophages; Male; Melanocyte-Stimulating Hormones; Mice; Molecular Targeted Therapy; Nanoparticles; Particle Size; Peptide Fragments; RAW 264.7 Cells; Sodium Dodecyl Sulfate; Static Electricity; Tumor Necrosis Factor-alpha | 2017 |